Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
+3.47%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$8.17B
AUM Growth
+$944M
(+13%)
Cap. Flow
+$596M
Cap. Flow
% of AUM
7.3%
Top 10 Holdings %
Top 10 Hldgs %
10.75%
Holding
2,067
New
470
Increased
467
Reduced
420
Closed
479
Top Buys
| 1 |
Micron Technology
MU
|
+$61.7M |
| 2 |
PayPal
PYPL
|
+$59.5M |
| 3 |
Zoetis
ZTS
|
+$57.1M |
| 4 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$55.6M |
Top Sells
| 1 |
SPLK
Splunk Inc
SPLK
|
+$254M |
| 2 |
NVIDIA
NVDA
|
+$93.4M |
| 3 |
Exxon Mobil
XOM
|
+$64M |
| 4 |
Aon
AON
|
+$43.4M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$39.4M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Healthcare | 12.17% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Industrials | 11.95% |
| 5 | Financials | 11.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
OppFi
OPFI
$297M
| $139K | ﹤0.01% |
+55,769
| New | +$139K |
|
|
BLUE
1352
DELISTED
bluebird bio
BLUE
| $138K | ﹤0.01% |
5,398
| – | – |
|
1353
Denison Mines
DNN
$2.18B
| $138K | ﹤0.01% |
+70,803
| New | +$138K |
|
1354
SGHC Ltd
SGHC
$6.55B
| $134K | ﹤0.01% |
38,751
| – | – |
|
1355
Beyond Meat
BYND
$199M
| $133K | ﹤0.01% |
16,086
-29,673
| -65% | -$246K |
|
|
ETRN
1356
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $127K | ﹤0.01% |
+10,203
| New | +$127K |
|
1357
uniQure
QURE
$931M
| $123K | ﹤0.01% |
23,653
-2,300
| -9% | -$12K |
|
|
DHC
1358
Diversified Healthcare Trust
DHC
$1.09B
| $122K | ﹤0.01% |
+49,607
| New | +$122K |
|
1359
Rocket Lab Corporation Common Stock
RKLB
$23.4B
| $116K | ﹤0.01% |
+28,228
| New | +$116K |
|
1360
Esperion Therapeutics
ESPR
$563M
| $116K | ﹤0.01% |
+43,214
| New | +$116K |
|
1361
BlackBerry
BB
$2.3B
| $110K | ﹤0.01% |
+39,723
| New | +$110K |
|
1362
Ventyx Biosciences
VTYX
$170M
| $106K | ﹤0.01% |
19,343
-19,235
| -50% | -$106K |
|
1363
Skillsoft
SKIL
$114M
| $104K | ﹤0.01% |
11,521
| – | – |
|
1364
Precigen
PGEN
$1.23B
| $104K | ﹤0.01% |
71,464
| – | – |
|
1365
Design Therapeutics
DSGN
$340M
| $102K | ﹤0.01% |
+25,327
| New | +$102K |
|
1366
Replimune Group
REPL
$471M
| $99.8K | ﹤0.01% |
+12,221
| New | +$99.8K |
|
1367
CytomX Therapeutics
CTMX
$346M
| $95.6K | ﹤0.01% |
43,865
-865
| -2% | -$1.89K |
|
1368
Senseonics Holdings
SENS
$374M
| $92.6K | ﹤0.01% |
174,383
| – | – |
|
1369
Cambium Networks
CMBM
$21.5M
| $91.8K | ﹤0.01% |
21,307
+5,214
| +32% | +$22.5K |
|
1370
DocGo
DCGO
$153M
| $90.2K | ﹤0.01% |
22,329
| – | – |
|
1371
United Microelectronic
UMC
$17B
| $87.2K | ﹤0.01% |
+10,774
| New | +$87.2K |
|
|
MREO
1372
Mereo BioPharma
MREO
$290M
| $86.4K | ﹤0.01% |
+26,179
| New | +$86.4K |
|
|
TVRD
1373
Tvardi Therapeutics, Inc. Common Stock
TVRD
$333M
| $84.7K | ﹤0.01% |
2,587
| – | – |
|
|
GOEV
1374
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $83.6K | ﹤0.01% |
+1,171
| New | +$83.6K |
|
|
CLYM
1375
Climb Bio, Inc. Common Stock
CLYM
$163M
| $80.7K | ﹤0.01% |
29,466
-24
| -0.1% | -$66 |
|